Alliance Unichem Poses Threat To Gehe's Position

27 November 1997

UK-based group Unichem has reached agreement on a proposed merger withFrance's Alliance Sante to form Alliance Unichem, subject to shareholder approval, thus potentially creating the biggest European drug wholesalers group after Germany's Gehe.

Close To L5 Billion Turnover The merger would make the new company the largest drugs wholesaler in the UK, Italy and Portugal, and the second largest in France. Alliance Unichem would also have significant market share in Morocco, Spain and Greece, creating a group with expected pretax profits for 1997 of some L102 million ($172 million), with a pro forma turnover in the region of L4.98 billion.

More interestingly, both the merged companies have been part of IPSO, a consortium of eight major pharmaceutical wholesalers, including Sanacorp and Anzag, the third largest German wholesaler, in which Unichem has an 8% stake. Indeed, some industry analysts argue that the merger may indicate that IPSO will be poised to challenge Gehe's pre-eminent position.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight